Swiss Medtech Labeling Demands And EU Equivalence Issue Await Authorities’ Position In Early 2022
Executive Summary
In spite of exchanges views with the Swiss authorities, the local medtech industry has so far failed to get its message across about the risk of product shortfalls if exporters to Switzerland must undergo additional requirements for the national market. But a glimmer of hope has emerged amid the growing confusion on the validity of the MRA.